Jack Research Development from 2010 to 2026

JNH Stock  CAD 0.01  0.00  0.00%   
Jack Nathan Research Development yearly trend continues to be fairly stable with very little volatility. Research Development is likely to outpace its year average in 2026. During the period from 2010 to 2026, Jack Nathan Research Development regression line of quarterly data had mean square error of 10.9 B and geometric mean of  131,189. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
134.9 K
Current Value
207 K
Quarterly Volatility
109.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jack Nathan financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jack Nathan's main balance sheet or income statement drivers, such as Interest Expense of 494.5 K, Selling General Administrative of 19.1 M or Total Revenue of 21 M, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or Days Sales Outstanding of 24.26. Jack financial statements analysis is a perfect complement when working with Jack Nathan Valuation or Volatility modules.
  
This module can also supplement various Jack Nathan Technical models . Check out the analysis of Jack Nathan Correlation against competitors.

Latest Jack Nathan's Research Development Growth Pattern

Below is the plot of the Research Development of Jack Nathan Medical over the last few years. It is Jack Nathan's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jack Nathan's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Jack Research Development Regression Statistics

Arithmetic Mean149,808
Geometric Mean131,189
Coefficient Of Variation73.36
Mean Deviation63,618
Median102,002
Standard Deviation109,896
Sample Variance12.1B
Range444.1K
R-Value0.39
Mean Square Error10.9B
R-Squared0.15
Significance0.12
Slope8,503
Total Sum of Squares193.2B

Jack Research Development History

2026207 K
2025134.9 K
2023149.9 K
2022236.9 K
2021546.1 K

About Jack Nathan Financial Statements

Jack Nathan investors use historical fundamental indicators, such as Jack Nathan's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jack Nathan. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development134.9 K207 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Jack Stock Analysis

When running Jack Nathan's price analysis, check to measure Jack Nathan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jack Nathan is operating at the current time. Most of Jack Nathan's value examination focuses on studying past and present price action to predict the probability of Jack Nathan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jack Nathan's price. Additionally, you may evaluate how the addition of Jack Nathan to your portfolios can decrease your overall portfolio volatility.